Výsledky vyhledávání - "Guillaume, Aussedat"

Akademický článek

End-of-life management of multiple myeloma patients in the era of CD38 and immunotherapy

Autor: Pierre Sesques, Lionel Karlin, Emmanuel Massy, Alizée Maarek, Guillaume Aussedat, Anne Lazareth, Camille Golfier, Fadhela Bouafia-Sauvy, Helene Lequeu, Dana Ghergus, Violaine Safar, Emmanuelle Ferrant, Emmanuel Bachy, Hervé Ghesquières, Cyrille B. Confavreux, Delphine Demangel, Emeline Perrial, Charles Dumontet

Publikováno v: Frontiers in Oncology, Vol 14 (2024)

BackgroundIn spite of spectacular advances in the treatment of multiple myeloma, a majority of patients will die from this disease or related complications. While a great amount of focus has been dedicated to the development of novel therapies, littl

Externí odkaz: https://doaj.org/article/4a125c6c53de4fb0b5064a8ef7afa57d

Zobrazit plný text záznamu

HLA-DR expression on monocytes and outcome of anti-CD19 CAR T-cell therapy for large B-cell lymphoma

Publikováno v: Blood Advances
Blood Advances, 2023, 7 (5), pp.744-755. ⟨10.1182/bloodadvances.2021006563⟩

Despite their unprecedented success in relapsed/refractory (R/R) large B-cell lymphoma (LBCL), anti-CD19 CAR T cells are associated with significant toxicity, and more than half of patients relapse. As monocytes emerged as key players in CAR therapy,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6334914490903dc8f9f76f2077aa2fa6
https://doi.org/10.1182/bloodadvances.2021006563

Zobrazit plný text záznamu

Outcome in Multiple Myeloma Patients Treated in the Era of Modern Therapies Who Were Admitted to Intensive Care: A Retrospective Analysis from a Teaching Hospital between 2014 and 2019

Autor: Zofia Gross, Maryam Idlhaj, Lionel Karlin, Arnaud Friggeri, Anne Lazareth, Camille Golfier, Helene Lequeu, Fadhela Bouafia Sauvy, Pierre Sesques, Violaine Safar, Emmanuelle Ferrant, Dana Ghergus, Alizee Maarek, Guillaume Aussedat, Gilles Salles, Emmanuel Bachy, Florent Wallet, Herve Ghesquieres

Publikováno v: Blood. 140:13099-13101

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0f91cc2be521f451f986a8ee71f78525
https://doi.org/10.1182/blood-2022-165911

Zobrazit plný text záznamu

Evaluation of Participation and Recruitment Bias in a Prospective Real-Life Multicentric Cohort « Real World Data in Lymphoma and Survival in Adults » (REALYSA study) for Newly Diagnosed Lymphoma Patients over One Year in a Hematology Department of Teaching Hospital

Publikováno v: Blood. 140:5210-5211

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b647e36b3ef6ccd294f68333699c6f39
https://doi.org/10.1182/blood-2022-164552

Zobrazit plný text záznamu

Lymphoma diagnosis: lessons learned from the comparison of histology and cytology associated with flow cytometry

Autor: Guillaume, Aussedat, Juliette, Fontaine, Luc-Marie, Gerland, Alexandra, Traverse-Glehen, Lucille, Baseggio

Publikováno v: Annales de biologie clinique. 80(2)

For lymphoma diagnosis, the flow cytometry (FCM) and cytology associated with FCM (C-FCM) performed on fine needle aspiration (FNA) or cell suspension/imprints from fresh tissue display a good concordance (from 85 to 90%) with the diagnosis made usin

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::d10217044d7ced75e3ed7d0ee3d070c8
https://pubmed.ncbi.nlm.nih.gov/35766066

Zobrazit plný text záznamu

Composite and sequential lymphoma between classical Hodgkin lymphoma and primary mediastinal lymphoma/diffuse large B‐cell lymphoma, a clinico‐pathological series of 25 cases

Publikováno v: British Journal of Haematology
British Journal of Haematology, Wiley, 2020, 189 (2), pp.244-256. ⟨10.1111/bjh.16331⟩

Composite and sequential lymphomas involving both classical Hodgkin lymphoma (CHL) and primary mediastinal B-cell lymphoma (PMBCL) are rare phenomena. Beyond the relevant biological interest raised by these cases, treatments and outcome data are poor

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30d7e775215c374e3da31d83d130d80b
https://doi.org/10.1111/bjh.16331

Zobrazit plný text záznamu

One translocation for 2 lymphoid neoplasms

Autor: Lucile Baseggio, Guillaume Aussedat

Publikováno v: Blood. 133(2)

[Figure][1] During the diagnostic workup of a 72-year-old man with anemia (83 g/L) with increased free κ light chain (140 mg/L), a bone marrow smear revealed infiltration by 25% of plasma cells (panel A, red arrows; original magnification ×60, May-

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc8b38dec000beae51729b5d9d3971d8
https://pubmed.ncbi.nlm.nih.gov/30630847

Zobrazit plný text záznamu

PVAG Regimen (Prednisone, Vinblastine, Doxorubicin, Gemcitabine) Used in Real-Life Setting in First Line Therapy for Elderly Classical Hodgkin Lymphoma Patients: A Retrospective Study of Lysa Centers

Autor: Amandine Durand, Adrien Chauchet, Xavier Roussel, Guillaume Aussedat, Pauline Brice, Gilles Salles, Maryam Idlhaj, Cédric Rossi, Hervé Ghesquières, Bénédicte Deau Fischer

Publikováno v: Blood. 136:11-11

Introduction: Older patients with an age above 60 years with classical Hodgkin lymphoma (cHL) represent a proportion of 20% to 30% of all cHL. Older cHL patients are characterized by unfavorable prognostic factors with an aggressive disease, a poor t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::fdceb9ac49e5b2809dc95d5530b00f6b
https://doi.org/10.1182/blood-2020-138706

Zobrazit plný text záznamu

Ritumixab in Combination with Adapted-Dose of Ifosfamide and Etoposide As Salvage Treatment in Elderly Refractory/Relapsed Diffuse Large B-Cell Lymphoma Patients Non-Candidate for High Dose Therapy: A Retrospective Study of Lyon Hospital University

Autor: Violaine Safar, Anne Lazareth, Pierre Sesques, Bertrand Favier, Lionel Karlin, Gilles Salles, Clémentine Sarkozy, Hervé Ghesquières, Emmanuel Bachy, Dana Ghergus, Emmanuelle Ferrant, Nicolas Vantard, Guillaume Aussedat, Delphine Maucort-Boulch, Emmanuelle Nicolas-Virelizier, Mad-Hélénie Elsensohn, Laure Lebras, Philippe Rey

Publikováno v: Blood. 132:4215-4215

Introduction: standard treatment for relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL) is high-dose chemotherapy followed by autologous stem-cell transplantation (ASCT) but this strategy is not appropriate for elderly DLBCL patients (pt

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e0c25a3e0f07d8c6894ed63c51dcf23b
https://doi.org/10.1182/blood-2018-99-116734

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání